American Academy of Dermatology (AAD) 2024 Annual Meeting

Disclaimer: This coverage is not sanctioned by, nor a part of, the American Academy of Dermatology.

• AAD 2024 Evidence Accumulating on Viral Cause of Cutaneous Granulomas
  MDedge News, May 9, 2024
• AAD 2024 Correct Dx of Cancer Treatment Skin Effects Evaluated
  Medscape Medical News, May 6, 2024
• AAD 2024 Hair Loss: Experts Provide Recommendations on Oral Minoxidil
  MDedge News, April 22, 2024
• AAD 2024 Neuromodulators: Rapid-Onset Option, Other Emerging Trends
  MDedge News, April 22, 2024
• AAD 2024 Does AD Severity Affect Growth in Children?
  Medscape Medical News, April 22, 2024
• AAD 2024 Alopecia Areata: Late Responses to JAK Inhibitors Reported
  MDedge News, April 14, 2024
• AAD 2024 Extension Data Reported for Chronic Hand Eczema Treatment
  Medscape Medical News, April 12, 2024
• AAD 2024 New Tool Could Help Screen Patients for Zoom Dysmorphia
  MDedge News, April 10, 2024
• AAD 2024 Expert Recommends Phased Approach For Delusional Infestation
  MDedge News, April 9, 2024
• AAD 2024 Hidradenitis Suppurativa: Sonelokimab Shows Promise in Study
  MDedge News, April 8, 2024
• AAD 2024 Transplant Recipients: Consider Skin Cancer, Infection Risks
  Medscape Medical News, April 5, 2024
• AAD 2024 Ruxolitinib Cream Shows Promise for Hidradenitis Suppurativa
  Medscape Medical News, April 3, 2024
• AAD 2024 Intralesional Wart Treatments Are Among Options to Consider
  MDedge News, April 2, 2024
• AAD 2024 JAK Inhibitors for Vitiligo: More Skin Response Over Time
  Medscape Medical News, April 2, 2024
• AAD 2024 AI in Dermatology: Consider Its Limitations and Problems
  Medscape Medical News, March 21, 2024
• AAD 2024 Roflumilast Cream Quickly Improved AD in Children, Ages 2-5
  Medscape Medical News, March 19, 2024
• AAD 2024 Tips on Managing Acne in Transmasculine Patients
  Medscape Medical News, March 18, 2024
• AAD 2024 Prurigo Nodularis: Nemolizumab Efficacy Persists at 52 Weeks
  Medscape Medical News, March 15, 2024
• AAD 2024 Major Responses Seen for Cicatricial and Total Hair Loss
  Medscape Medical News, March 14, 2024
• AAD 2024 2024 AAD Acne Guidelines: Newer Therapies Join Old Standbys
  Medscape Medical News, March 13, 2024
• AAD 2024 Lebrikizumab Found Effective for Patients With AD, SOC
  Medscape Medical News, March 12, 2024
• AAD 2024 Study Eyes Effect of Maternal HS on Outcomes in Offspring
  Medscape Medical News, March 11, 2024
• AAD 2024 Anti-IL-17, Anti-IL-23 Rxs Show Sustained Psoriasis Control
  Medscape Medical News, March 10, 2024
• AAD 2024 Home- and Office-Based Phototherapy for Psoriasis Compared
  Medscape Medical News, March 10, 2024
• AAD 2024 During Pregnancy, Many Drugs Safe for Skin Infections
  Medscape Medical News, March 10, 2024
• AAD 2024 New NCCN Melanoma Guidelines Capture Evolving Best Practice
  Medscape Medical News, March 9, 2024
• AAD 2024 Novel Drug Shows Promise for Hidradenitis Suppurativa
  Medscape Medical News, March 9, 2024
• AAD 2024 Flexibility Advised for Patients With Personality Disorders
  Medscape Medical News, March 8, 2024